Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Brown

Showing results (501-510 of 597) with videos related to

Pageof 60
Sort By:
The Annals of Thoracic Surgery|February 7, 2018
Major Adverse Renal and Cardiac Events After Coronary Angiography and Cardiac SurgeryKristen M Tecson, David Brown, James W Choi, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline MimeticsJean-Baptiste Garsi, Balázs Komjáti, Gregorio Cullia, et al.
Journal of Medicinal Chemistry|August 31, 2018
Design and Characterization of Novel Covalent Bromodomain and Extra-Terminal Domain (BET) Inhibitors Targeting a MethionineOlesya A Kharenko, Reena G Patel, S David Brown, et al.
Journal of Clinical Microbiology|November 8, 2013
Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinicVikrant V Sahasrabuddhe, Patti E Gravitt, S Terence Dunn, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2007
Selective and dual action orally active inhibitors of thrombin and factor XaRobert J Young, David Brown, Cynthia L Burns-Kurtis, et al.
The Journal of Infectious Diseases|December 6, 2007
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratoriesMarcus Panning, Thomas Laue, Stephan Olschlager, et al.
Journal of Medicinal Chemistry|November 5, 2016
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of PainSarah E Skerratt, Mark Andrews, Sharan K Bagal, et al.
Journal of Medicinal Chemistry|March 21, 2020
Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal CompoundsIrene G Salado, Abhimanyu K Singh, Carlos Moreno-Cinos, et al.
Global Change Biology|August 5, 2025
Coexistence, Extinction and Survival-The Evolutionary History of Bison Species in Western EurasiaBastien Llamas, Ayla L van Loenen, Kieren J Mitchell, et al.
Brain, Behavior, and Immunity|October 17, 2023
Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trialThomas W Weickert, Isabella Jacomb, Rhoshel Lenroot, et al.
Pageof 60

Showing results (501-510 of 597) with videos related to

Sort By:
Pageof 60
The Annals of Thoracic Surgery|February 7, 2018
Major Adverse Renal and Cardiac Events After Coronary Angiography and Cardiac SurgeryKristen M Tecson, David Brown, James W Choi, et al.
ACS Medicinal Chemistry Letters|June 16, 2022
Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline MimeticsJean-Baptiste Garsi, Balázs Komjáti, Gregorio Cullia, et al.
Journal of Medicinal Chemistry|August 31, 2018
Design and Characterization of Novel Covalent Bromodomain and Extra-Terminal Domain (BET) Inhibitors Targeting a MethionineOlesya A Kharenko, Reena G Patel, S David Brown, et al.
Journal of Clinical Microbiology|November 8, 2013
Comparison of human papillomavirus detections in urine, vulvar, and cervical samples from women attending a colposcopy clinicVikrant V Sahasrabuddhe, Patti E Gravitt, S Terence Dunn, et al.
Bioorganic & Medicinal Chemistry Letters|April 11, 2007
Selective and dual action orally active inhibitors of thrombin and factor XaRobert J Young, David Brown, Cynthia L Burns-Kurtis, et al.
The Journal of Infectious Diseases|December 6, 2007
Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratoriesMarcus Panning, Thomas Laue, Stephan Olschlager, et al.
Journal of Medicinal Chemistry|November 5, 2016
The Discovery of a Potent, Selective, and Peripherally Restricted Pan-Trk Inhibitor (PF-06273340) for the Treatment of PainSarah E Skerratt, Mark Andrews, Sharan K Bagal, et al.
Journal of Medicinal Chemistry|March 21, 2020
Lead Optimization of Phthalazinone Phosphodiesterase Inhibitors as Novel Antitrypanosomal CompoundsIrene G Salado, Abhimanyu K Singh, Carlos Moreno-Cinos, et al.
Global Change Biology|August 5, 2025
Coexistence, Extinction and Survival-The Evolutionary History of Bison Species in Western EurasiaBastien Llamas, Ayla L van Loenen, Kieren J Mitchell, et al.
Brain, Behavior, and Immunity|October 17, 2023
Adjunctive canakinumab reduces peripheral inflammation markers and improves positive symptoms in people with schizophrenia and inflammation: A randomized control trialThomas W Weickert, Isabella Jacomb, Rhoshel Lenroot, et al.
Pageof 60